Home7ZT • FRA
add
Hamlet BioPharma AB
Previous close
€0.59
Day range
€0.59 - €0.60
Year range
€0.33 - €0.63
Avg Volume
175.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.58M | 7.58% |
Net income | -15.43M | -7.26% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -13.03M | -9.95% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.64M | -45.25% |
Total assets | 46.20M | -38.39% |
Total liabilities | 7.59M | 46.46% |
Total equity | 38.62M | — |
Shares outstanding | 184.66M | — |
Price to book | 2.80 | — |
Return on assets | -74.12% | — |
Return on capital | -84.07% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -15.43M | -7.26% |
Cash from operations | -11.56M | 8.36% |
Cash from investing | -353.00K | -1,316.42% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -11.91M | -185.85% |
Free cash flow | -6.22M | 14.85% |
About
Founded
2015
Website
Employees
7
